Recent Finacing
Recent Raise
Neuroglee Therapeutics develops prescription digital therapeutics for neurodegenerative diseases, offering NG-001, an adaptive ML-driven tablet therapy for Alzheimer’s with biometric tracking, clinician-facing Neuroglee Connect, and home-based care.
